Ativan and Hyperacusis - a phase IV clinical study of FDA data

Summary:

Hyperacusis is reported as a side effect among people who take Ativan (lorazepam), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Klonopin, and have Depression.

The phase IV clinical study analyzes which people have Hyperacusis when taking Ativan. It is created by eHealthMe based on reports of 74,376 people who have side effects when taking Ativan from the FDA, and is updated regularly.

What is Ativan?

Ativan has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 78,505 Ativan users. Check the latest studies of Ativan.

What is Hyperacusis?

Hyperacusis (disorder in loudness perception) is found to be associated with 411 drugs and 608 conditions by eHealthMe. Check the latest studies of Hyperacusis.

On Jun, 20, 2026

74,376 people reported to have side effects when taking Ativan.
Among them, 64 people (0.09%) have Hyperacusis.

Among these 64 people:

How long have people been on Ativan when they have Hyperacusis? *

What is the gender of people who have Hyperacusis when taking Ativan? *

female: 70.49 %
male: 29.51 %

What is the age of people who have Hyperacusis when taking Ativan? *

What are other drugs people take besides Ativan? *

What are other side effects people have besides Hyperacusis? *

Photophobia (extreme sensitivity to light): 32 people, 50.00%
Headache (pain in head): 25 people, 39.06%
Fatigue (feeling of tiredness): 19 people, 29.69%
Pain: 15 people, 23.44%
Memory Loss: 13 people, 20.31%
Tinnitus (a ringing in the ears): 13 people, 20.31%
Suicidal Ideation: 13 people, 20.31%
Dizziness: 13 people, 20.31%
Weight Decreased: 12 people, 18.75%
Nausea (feeling of having an urge to vomit): 12 people, 18.75%

What are the existing conditions these people have? *

Sleep Disorder: 8 people, 12.50%
Depression: 8 people, 12.50%
Pain: 7 people, 10.94%
Skin Wrinkling (wrinkle on skin): 4 people, 6.25%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 4 people, 6.25%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 6.25%
Bipolar Disorder (mood disorder): 3 people, 4.69%
Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 4.69%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 3 people, 4.69%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 3 people, 4.69%

* Approximation only. Some reports may have incomplete information.

Do you take Ativan and have Hyperacusis?

- Check whether Hyperacusis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ativan:

Ativan (78,505 reports)

Hyperacusis treatments and more:

Hyperacusis (4,388 reports)

Browse all side effects of Ativan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperacusis:

Hyperacusis (411 drugs)

Browse all the conditions that are associated with Hyperacusis:

Hyperacusis (608 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam (the active ingredients of Ativan) and Ativan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.